Abstract
Cardiogenic shock (CS) is increasingly recognized in patients with malignancies, while cancer is independently associated with worse prognosis in CS. A number of conditions may lead to CS in cancer, including acute coronary syndromes, cardiomyopathy, takotsubo syndrome, myocarditis, pulmonary embolism, tamponade, and cardiac herniation. In these conditions, CS may be related to cancer itself or to cancer therapy, including surgery, chemotherapy, or radiotherapy. Given the significantly improved overall survival of patients with malignancies, the early recognition and proper management of CS in cancer become increasingly important. In the present paper, we review the available evidence on CS in patients with malignancies and highlight issues related to its management.
Similar content being viewed by others
References
Tubaro M, Vranckx P, Price S, Vrints C, European Society of C. The ESC textbook of intensive and acute cardiovascular care. 2016
Chioncel O, Mebazaa A, Harjola VP, Coats AJ, Piepoli MF, Crespo-Leiro MG, Laroche C, Seferovic PM, Anker SD, Ferrari R, Ruschitzka F, Lopez-Fernandez S, Miani D, Filippatos G, Maggioni AP, on behalf of the ESC Heart Failure Long-Term Registry Investigators (2017) Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry. Eur J Heart Fail 19(10):1242–1254
Puymirat E, Fagon JY, Aegerter P et al (2017) Cardiogenic shock in intensive care units: evolution of prevalence, patient profile, management and outcomes, 1997–2012. Eur J Heart Failure 19(2):192–200
Shaefi S, O’Gara B, Kociol RD, Joynt K, Mueller A, Nizamuddin J, Mahmood E, Talmor D, Shahul S (2015) Effect of cardiogenic shock hospital volume on mortality in patients with cardiogenic shock. J Am Heart Assoc 4(1):e001462
Rodriguez M, Sabharwal B, Wei X, Krittanawong C, Verheyen E, Herzog E. The effect of cancer on outcomes on acute heart failure exacerbations: a 5-year nationwide analysis. 2018;71(11 Supplement):A693
Iliescu CA, Grines CL, Herrmann J et al (2016) SCAI expert consensus statement: evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory (endorsed by the cardiological society of India, and sociedad Latino Americana de Cardiologia intervencionista). Catheter Cardiovasc Interv 87(5):E202–E223
Park JY, Al-Hijji M, El Sabbagh A et al (2016) Acute coronary syndrome in active hematological malignancies: a cohort study of 5,300 patients. JACC 67(13 Supplement):585
Navi BB, Reiner AS, Kamel H, Iadecola C, Okin PM, Elkind MSV, Panageas KS, DeAngelis LM (2017) Risk of arterial thromboembolism in patients with cancer. J Am Coll Cardiol 70(8):926–938
Lim SH, Wilson SM, Hunter A, Hill J, Beale P (2013) Takotsubo cardiomyopathy and 5-fluorouracil: getting to the heart of the matter. Case Rep Oncol Med 2013:206765
Rohrmann S, Witassek F, Erne P, Rickli H, Radovanovic D (2018) Treatment of patients with myocardial infarction depends on history of cancer. Eur Heart J Acute Cardiovasc Care 7(7):639–645
Velders MA, Boden H, Hofma SH, Osanto S, van der Hoeven BL, Heestermans AACM, Cannegieter SC, Jukema JW, Umans VAWM, Schalij MJ, van Boven AJ (2013) Outcome after ST elevation myocardial infarction in patients with cancer treated with primary percutaneous coronary intervention. Am J Cardiol 112(12):1867–1872
Sulpher J, Dattilo F, Dent S, Turek M, Reaume MN, Johnson C. Acute cardiogenic shock induced by infusional 5-fluorouracil. Case Rep Oncol Med 2014;2014:819396
Zamorano JL, Lancellotti P, Rodriguez Munoz D, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J 2016;37(36):2768–2801
Manual of cardio-oncology. Cardiovascular care in the cancer patient. 2017 ed: Springer International Publishing Switzerland 2017; 2017
Ozaki T, Chiba S, Annen K, Kawamukai Y, Kohno N, Horimoto M (2010) Acute coronary syndrome due to coronary artery compression by a metastatic cardiac tumor. J Cardiol Cases 1(1):e52–ee5
Nogales-Romo MT, Tirado G, Freitas-Ferraz A, Martínez-Losas P, Rodrigo JL, Alswies A, Saiz-Pardo M, Ruiz-Mateos B, Viana-Tejedor A, Fernández-Ortiz A, Macaya C, Núñez-Gil IJ (2016) Coronary embolism of left atrial myxoma coexisting with severe aortic stenosis and atherosclerotic coronary disease. Int J Cardiol 203:315–316
Noguchi M, Yamada Y, Sakakura K, Katayama T, Momomura S, Ako J (2016) Coronary thrombus aspiration revealed tumorous embolism of myxofibrosarcoma from the left atrium. Cardiovasc Interv Ther 31(1):75–78
Antonopoulos AS, Chrysohoou C, Lymperiadis D, Brili S, Tousoulis D (2016) Peripheral and coronary artery embolisms due to left ventricle fibroelastoma. Hell J Cardiol 57(5):368–370
Aronson D, Brenner B (2018) Arterial thrombosis and cancer. Thromb Res 164(Suppl 1):S23–Ss8
Farmakis D, Mantzourani M, Filippatos G (2018) Anthracycline-induced cardiomyopathy: secrets and lies. Eur J Heart Fail 20(5):907–909
Cardinale D, Colombo A, Bacchiani G, Tedeschi I, Meroni CA, Veglia F, Civelli M, Lamantia G, Colombo N, Curigliano G, Fiorentini C, Cipolla CM (2015) Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation. 131(22):1981–1988
Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, Cammann VL, Crea F, Galiuto L, Desmet W, Yoshida T, Manfredini R, Eitel I, Kosuge M, Nef HM, Deshmukh A, Lerman A, Bossone E, Citro R, Ueyama T, Corrado D, Kurisu S, Ruschitzka F, Winchester D, Lyon AR, Omerovic E, Bax JJ, Meimoun P, Tarantini G, Rihal C, Y.-Hassan S, Migliore F, Horowitz JD, Shimokawa H, Lüscher TF, Templin C International expert consensus document on Takotsubo syndrome (part I): clinical characteristics, diagnostic criteria, and pathophysiology. Eur Heart J 2018;39(22):2032–2046
Giza DE, Lopez-Mattei J, Vejpongsa P et al (2017) Stress-induced cardiomyopathy in cancer patients. Am J Cardiol 120(12):2284–2288
Munoz E, Iliescu G, Vejpongsa P, Charitakis K, Karimzad K, Lopez-Mattei J, Yusuf SW, Marmagkiolis K, Iliescu C (2016) Takotsubo stress cardiomyopathy: “good news” in cancer patients? J Am Coll Cardiol 68(10):1143–1144
Fernandez SF BM, Canty JM Jr. Takotsubo cardiomyopathy following initial chemotherapy presenting with syncope and cardiogenic shock – a case report and literature review. J Clin Exp Cardiol 2:124 2011
Burgdorf C, Kurowski V, Bonnemeier H, Schunkert H, Radke PW (2008) Long-term prognosis of the transient left ventricular dysfunction syndrome (Tako-Tsubo cardiomyopathy): focus on malignancies. Eur J Heart Fail 10(10):1015–1019
Madias JE (2016) What is/are the trigger(s) of takotsubo syndrome in cancer patients receiving chemotherapy? Int J Cardiol 222:253
Franco TH, Khan A, Joshi V, Thomas B (2008) Takotsubo cardiomyopathy in two men receiving bevacizumab for metastatic cancer. Ther Clin Risk Manag 4(6):1367–1370
Santos JRU, Brofferio A, Viana B, Pacak K (2018) Catecholamine-induced cardiomyopathy in pheochromocytoma: how to manage a rare complication in a rare disease? Horm Metab Res
Bergland BE (1989) Pheochromocytoma presenting as shock. Am J Emerg Med 7(1):44–48
Assefa D, Welsch J, Laubner K, Burgdorf C, Kotzerke M (2015) Cardiogenic shock due to atypical Tako-Tsubo cardiomyopathy in a young woman with pheochromocytoma. Deutsche medizinische Wochenschrift (1946). 140(6):422–425
Chiang YL, Chen PC, Lee CC, Chua SK (2016) Adrenal pheochromocytoma presenting with Takotsubo-pattern cardiomyopathy and acute heart failure: a case report and literature review. Medicine. 95(36):e4846
Di Palma G, Daniele GP, Antonini-Canterin F, Piazza R, Nicolosi GL (2010) Cardiogenic shock with basal transient left ventricular ballooning (Takotsubo-like cardiomyopathy) as first presentation of pheochromocytoma. J Cardiovasc Med (Hagerstown) 11(7):507–510
Law C, Khaliq A, Guglin M (2013) Reversible cardiogenic shock due to catecholamine-induced cardiomyopathy: a variant of takotsubo? Am J Emerg Med 31(11):1621.e1–1621.e3
Hekimian G, Kharcha F, Brechot N et al (2016) Extracorporeal membrane oxygenation for pheochromocytoma-induced cardiogenic shock. Ann Intensive Care 6(1):117
Flam B, Broome M, Frenckner B, Branstrom R, Bell M (2015) Pheochromocytoma-induced inverted takotsubo-like cardiomyopathy leading to cardiogenic shock successfully treated with extracorporeal membrane oxygenation. J Intensive Care Med 30(6):365–372
Tsibiribi P, Bui-Xuan C, Bui-Xuan B, Lombard-Bohas C, Duperret S, Belkhiria M, Tabib A, Maujean G, Descotes J, Timour Q (2006) Cardiac lesions induced by 5-fluorouracil in the rabbit. Hum Exp Toxicol 25(6):305–309
Sasson Z, Morgan CD, Wang B, Thomas G, MacKenzie B, Platts ME (1994) 5-Fluorouracil related toxic myocarditis: case reports and pathological confirmation. Can J Cardiol 10(8):861–864
Sellier-Leclerc AL, Belli E, Guerin V, Dorfmuller P, Deschenes G (2013) Fulminant viral myocarditis after rituximab therapy in pediatric nephrotic syndrome. Pediatr Nephrol 28(9):1875–1879
Alonso JJ, Canovas A, Rubio G (2013) Lethal enterovirus myocarditis associated with rituximab and chemotherapy for follicular lymphoma. Med Clin 141(10):459–460
Asnani A (2018) Cardiotoxicity of immunotherapy: incidence, diagnosis, and management. Curr Oncol Rep 20(6):44
Johnson DB, Balko JM, Compton ML et al (2016) Fulminant myocarditis with combination immune checkpoint blockade. N Eng J Med 375(18):1749–1755
Sauer R, Kiewe P, Desole M et al (2017) Lymphocytic myocarditis in a patient with metastatic clear cell renal cell carcinoma treated with nivolumab. Pathologe 38(6):535–539
Cheung CC, Constantine M, Ahmadi A, Shiau C, Chen LYC (2017) Eosinophilic myocarditis. Am J Med Sci 354(5):486–492
Biedka M, Ziolkowska E, Windorbska W (2012) Acute pulmonary embolus in the course of cancer. Contemp Oncol 16(5):388–393
Silva P, Rosales M, Milheiro MJ, Santos LL (2015) Pulmonary embolism in ambulatory oncologic patients. Acta Med Port 28(4):463–468
Bach AG, Neumann J, Taute BM, Surov A (2016) Frequency, cause, and awareness of pulmonary embolism in oncologic patients. Dtsch Med Wochenschr 141(10):713–717
Jones DH, Schlatter MG, Cornelius AS, Neirotti RA (2000) A massive pulmonary tumor embolism after surgical manipulation and biopsy of a pelvic mass. Anesth Analg 90(2):322–323
Choi EJ, Jin GY (2017) Pulmonary embolism after percutaneous cryoablation for lung cancer: a case report. J Vasc Interv Radiol 28(9):1285–1287
Lin HF, Liao KF, Chang CM, Lin CL, Lai SW, Hsu CY (2018) Correlation of the tamoxifen use with the increased risk of deep vein thrombosis and pulmonary embolism in elderly women with breast cancer: a case-control study. Medicine. 97(51):e12842
Keefe D, Bowen J, Gibson R, Tan T, Okera M, Stringer A (2011) Noncardiac vascular toxicities of vascular endothelial growth factor inhibitors in advanced cancer: a review. Oncologist 16(4):432–444
Bois MC, Eckhardt MD, Cracolici VM et al (2018) Neoplastic embolization to systemic and pulmonary arteries. J Vasc Surg 68(1):204–212 e7
von Herbay A, Illes A, Waldherr R, Otto HF (1990) Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension. Cancer. 66(3):587–592
Han S, Kreit J (2013) 1242: Cardiogenic shock from pulmonary tumor thrombotic microangiopathy. 41(12):A319
Ohguchi H, Imaeda K, Hotta A, Kakoi S, Yasuda S, Shimizu Y, Hayakawa A, Mishina H, Hasegawa C, Ito S, Ogawa K, Yagi T, Koyama H, Tanaka T, Kato H, Takahashi S, Joh T (2018) An autopsy case of pulmonary tumor thrombotic microangiopathy due to rapidly progressing colon cancer in a patient with type 2 diabetes. Intern Med 57(17):2533–2539
Vincent F, Lamblin N, Classe M, Schurtz G, Rauch A, Fertin M, de Groote P (2017) Subacute right heart failure revealing three simultaneous causes of post-embolic pulmonary hypertension in metastatic dissemination of breast cancer. ESC Heart Fail 4(1):75–77
Seol SH, Park BM, Jin HY, Kim DI (2013) Fatal acute right heart failure in gastric cancer patients. Heart Views 14(4):179–181
Okubo Y, Wakayama M, Kitahara K, Nemoto T, Yokose T, Abe F, Hiruta N, Sasai D, Shinozaki M, Nakayama H, Ishiwatari T, Shibuya K (2011) Pulmonary tumor thrombotic microangiopathy induced by gastric carcinoma: morphometric and immunohistochemical analysis of six autopsy cases. Diagn Pathol 6:27
Tsujimoto N, Miyoshi A, Mimura M, Naka T, Yamasaki M, Yokoi T (2018) Case report: pulmonary tumor thrombotic microangiopathy in a cervical cancer patient. Gynecol Obstet Investig 83(1):99–104
Purga SL, Narula N, Horn EM, Karas MG (2015) Pulmonary tumour thrombotic microangiopathy as a cause of new-onset pulmonary hypertension in a patient with metastatic low-grade serous ovarian cancer. BMJ Case Rep 2015
Takayama T, Okura Y, Okada Y, Honma K, Nashimoto A, Sato N, Yokoyama A, Minamino T (2015) Characteristics of neoplastic cardiac tamponade and prognosis after pericardiocentesis: a single-center study of 113 consecutive cancer patients. Int J Clin Oncol 20(5):872–877
Khan UA, Shanholtz CB, McCurdy MT (2017) Oncologic mechanical emergencies. Hematol Oncol Clin North Am 31(6):927–940
Abdelnaby M, Almaghraby A, Saleh Y, Abayazeed R (2018) Pericardial sarcoma. BMJ Case Rep 2018
Chen YY, Huang WC, Huang MH, Lu TM, Hsu CP (2018) The intra-pericardial paraganglioma presenting as ascites and hemopericardium with impending tamponade. Int Heart J 59(3):664–667
Nagarsheth NP, Harrison M, Kalir T, Rahaman J (2006) Malignant pericardial effusion with cardiac tamponade in a patient with metastatic vaginal adenocarcinoma. Int J Gynecol Cancer 16(3):1458–1461
Oka Y, Okada K, Miyake Y, et al. [Three cases of gastric cancer with rare presentation of oncologic emergency]. Gan to kagaku ryoho Cancer & chemotherapy 2016;43(12):2398–2400
Chen X, Miao Q, Yu Y et al Blunt trauma-induced pericardial tamponade after video-assisted thoracoscopic surgery. Ann Thorac Surg
Chung MW, Ha SY, Choi JH, Park HJ, Myung DS, Cho SB, Lee WS, Kim JW, Oh HH, Joo YE (2018) Cardiac tamponade after radiofrequency ablation for hepatocellular carcinoma: case report and literature review. Medicine. 97(49):e13532
Gonzalo Baron Esquivias RA (2015) Cardiac management of oncology patients. Springer
Sundaram VR, Abbas T (2018) Cardiac tamponade induced by dabrafenib and trametinib combination therapy for melanoma: case report. Medicine. 97(44):e12751
Burkhart T, Keith MCL, Lenneman CAG, Fernando RR (2018) Bortezomib-induced cardiac tamponade in a 49-year-old man. Tex Heart Inst J 45(4):260–263
Asai M, Kato Y, Kawai S, et al. Management of cardiac tamponade during nivolumab of lung cancer with intrapericardial bleomycin: case report2019
Zhao Y, Liu S (2017) Acute cardiac herniation after left Intrapericardial pneumonectomy. J Cardiothorac Vasc Anesth 31(1):270–273
Alimi F, Marzouk M, Mgarrech I, Chemchik H, Limayem F (2016) Cardiac herniation after left intrapericardial pneumonectomy. Asian Cardiovasc Thorac Ann 24(6):590–592
Zandberg FT, Verbeke SJ, Snijder RJ, Dalinghaus WH, Roeffel SM, Van Swieten HA (2004) Sudden cardiac herniation 6 months after right pneumonectomy. Ann Thorac Surg 78(3):1095–1097
Norwood TG, Westbrook BC, Johnson DB, Litovsky SH, Terry NL, McKee SB, Gertler AS, Moslehi JJ, Conry RM (2017) Smoldering myocarditis following immune checkpoint blockade. J Immunother Cancer 5(1):91
Keenan NG, Nicholson AG, Oldershaw PJ (2008) Fatal acute pulmonary hypertension caused by pulmonary tumour thrombotic microangiopathy. Int J Cardiol 124(1):e11–e13
Miyazaki S, Ikeda T, Ito G, Inoue M, Nara K, Nishinaga Y, Hasegawa Y (2017) Pulmonary tumor thrombotic microangiopathy successfully treated with corticosteroids: a case report. J Med Case Rep 11(1):356
Ogawa A, Yamadori I, Matsubara O, Matsubara H (2013) Pulmonary tumor thrombotic microangiopathy with circulatory failure treated with imatinib. Intern Med 52(17):1927–1930
Higo K, Kubota K, Takeda A, Higashi M, Ohishi M (2014) Successful antemortem diagnosis and treatment of pulmonary tumor thrombotic microangiopathy. Intern Med 53(22):2595–2599
Reynen K, Kockeritz U, Strasser RH (2004) Metastases to the heart. Ann Oncol 15(3):375–381
Lestuzzi C (2010) Neoplastic pericardial disease: old and current strategies for diagnosis and management. World J Cardiol 2(9):270–279
Farmakis D, Keramida K, Filippatos G (2018) How to build a cardio-oncology service? Eur J Heart Fail 20(12):1732–1734
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Keramida, K., Parissis, J.T., Chioncel, O. et al. Cardiogenic shock in cancer. Heart Fail Rev 24, 997–1004 (2019). https://doi.org/10.1007/s10741-019-09819-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10741-019-09819-9